Lucas Opazo-Rios
Overview
Explore the profile of Lucas Opazo-Rios including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Caballero C, Guerrero-Hue M, Vallejo-Mudarra M, Palomino Antolin A, Decouty-Perez C, Sanchez-Mendoza L, et al.
Free Radic Biol Med
. 2024 Oct;
225:430-444.
PMID: 39413979
Massive intravascular hemolysis occurs not unfrequently in many clinical conditions. Breakdown of erythrocytes promotes the accumulation of heme-derivates in the kidney, increasing oxidative stress and cell death, thus promoting acute...
2.
Soto-Catalan M, Opazo-Rios L, Quiceno H, Lazaro I, Moreno J, Gomez-Guerrero C, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38474208
Metabolic-dysfunction-associated steatotic liver disease (MASLD) is a prevalent clinical condition associated with elevated morbidity and mortality rates. Patients with MASLD treated with semaglutide, a glucagon-like peptide-1 receptor agonist, demonstrate improvement...
3.
Rayego-Mateos S, Morgado-Pascual J, Garcia-Caballero C, Lazaro I, Sala-Vila A, Opazo-Rios L, et al.
J Pathol
. 2023 Aug;
261(2):169-183.
PMID: 37555366
Intravascular hemolysis is a common feature of different clinical entities, including sickle cell disease and malaria. Chronic hemolytic disorders are associated with hepatic damage; however, it is unknown whether heme...
4.
Jimenez-Castilla L, Opazo-Rios L, Marin-Royo G, Orejudo M, Rodrigues-Diez R, Ballesteros-Martinez C, et al.
Antioxidants (Basel)
. 2022 Dec;
11(12).
PMID: 36552707
In diabetes, chronic hyperglycemia, dyslipidemia, inflammation and oxidative stress contribute to the progression of macro/microvascular complications. Recently, benefits of the use of flavonoids in these conditions have been established. This...
5.
Vazquez-Carballo C, Herencia C, Guerrero-Hue M, Garcia-Caballero C, Rayego-Mateos S, Morgado-Pascual J, et al.
J Pathol
. 2022 Jul;
258(3):236-249.
PMID: 35903022
Massive intravascular hemolysis is a common characteristic of several pathologies. It is associated with the release of large quantities of heme into the circulation, promoting injury in vulnerable organs, mainly...
6.
Opazo-Rios L, Soto-Catalan M, Lazaro I, Sala-Vila A, Jimenez-Castilla L, Orejudo M, et al.
Int J Mol Sci
. 2022 Apr;
23(7).
PMID: 35409324
Metabolic associated fatty liver disease (MAFLD) is a hepatic manifestation of metabolic syndrome and usually associated with obesity and diabetes. Our aim is to characterize the pathophysiological mechanism involved in...
7.
Opazo-Rios L, Tejera-Munoz A, Soto Catalan M, Marchant V, Lavoz C, Fontao S, et al.
Front Pharmacol
. 2022 Apr;
13:778776.
PMID: 35370692
Diabetic nephropathy (DN) is the main leading cause of chronic kidney disease worldwide. Although remarkable therapeutic advances have been made during the last few years, there still exists a high...
8.
Jimenez-Castilla L, Marin-Royo G, Orejudo M, Opazo-Rios L, Caro-Ordieres T, Artaiz I, et al.
Antioxidants (Basel)
. 2021 Dec;
10(12).
PMID: 34943023
Diabetes mellitus (DM) is a high-impact disease commonly characterized by hyperglycemia, inflammation, and oxidative stress. Diabetic nephropathy (DN) is a common diabetic microvascular complication and the leading cause of chronic...
9.
[Creation of the Exercise and Chronic Kidney Disease Committee of the Chilean Society of Nephrology]
Muller-Ortiz H, Moscoso-Aguayo P, Gonzalez-Burboa A, Vera-Calzaretta A, Opazo-Rios L, Basaez-Fernandez A, et al.
Rev Med Chil
. 2021 Sep;
149(3):478-479.
PMID: 34479330
No abstract available.
10.
Vazquez-Carballo C, Guerrero-Hue M, Garcia-Caballero C, Rayego-Mateos S, Opazo-Rios L, Morgado-Pascual J, et al.
Int J Mol Sci
. 2021 Jan;
22(2).
PMID: 33467524
Acute kidney injury (AKI) is an important health problem, affecting 13.3 million individuals/year. It is associated with increased mortality, mainly in low- and middle-income countries, where renal replacement therapy is...